Ascendis Pharma A/S
ASND
$168.84
$15.8610.37%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/18/2025
-
Tickeron - Stocks
Ascendis Pharma A/S (ASND, $152.98) Stochastic Oscillator left the overbought zone on March 14, 2025
3/15/2025
-
Tickeron - Stocks
3/13/2025
-
Tickeron - Stocks
3/13/2025
-
Simply Wall St
3/12/2025
-
MarketBeat
3/11/2025
-
Tickeron - Stocks
3/11/2025
-
Tickeron - Stocks
Ascendis Pharma A/S (ASND, $145.74) price may climb as it broke lower Bollinger Band on Mar 07, 2025
3/8/2025
-
Tickeron - Stocks
3/7/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/6/2025
-
Ticker Report
3/4/2025
-
Tickeron - Stocks
3/2/2025
-
MarketBeat
3/1/2025
-
Ticker Report
2/28/2025
-
MarketBeat
2/26/2025
-
MarketBeat
2/25/2025
-
Ticker Report
2/25/2025
-
MarketBeat
2/24/2025
-
Globe Newswire
2/21/2025
-
MarketBeat
2/19/2025
-
MarketBeat
2/18/2025
-
Ticker Report
2/18/2025
-
MarketBeat
2/17/2025
-
MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Yearly Results: Here's What Analysts Are Forecasting For This Year
2/15/2025
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
45 70 22 22 44
Address
Tuborg Boulevard 12
Hellerup, 2900
Hellerup, 2900
Country
Year Founded
Business Description
Sector
--
Industry
--
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The...
more